resbiotic
PrivateLast Round
Series A
Sep 12, 2025
Total Funding Raised
$15.5M
Momentum Score
25 /100
Company Overview
resbiotic is a biotechnology company that provides physician-formulated dietary supplements, including probiotics and prebiotics, to support respiratory and gut health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Clinical Trials, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
resbiotic Comps
Public and private peers based on sector, stage, and business model.
resbiotic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2025 | ||||
| Seed | Oct 26, 2021 | ||||
| Seed | Apr 29, 2021 |
resbiotic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biostack Ventures | Series A |
| Timberline Holdings | Seed |
| First Avenue Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Products launched in H-E-B stores.
- Apr 9, 2026
Products launched in Walgreens stores.
resbiotic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about resbiotic's valuation, stock price, and market status.
